EXHIBIT 10.1 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASSIGNMENT AND...Stock Purchase Agreement • July 27th, 2005 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
NEUROCRINE BIOSCIENCES, INC. ANDRights Agreement • August 11th, 1999 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.6 Warrant Agreement dated June 30, 1998 between Neurocrine Biosciences, Inc., a Delaware corporation (the "Company"), and Stephen L. Ross ("Holder"). Whereas Holder and the Company are parties to a certain Sublicense and Development...Warrant Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
WITNESSETH:License Agreement • March 17th, 2004 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
ANDAgreement and Plan of Reorganization • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
FOROperating Agreement • November 14th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
ARTICLE 1Employment Agreement • August 11th, 2000 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
Exhibit 1.1 [_______________] Shares Neurocrine Biosciences, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT December [__], 2001 Deutsche Banc Alex. Brown Inc. Credit Suisse First Boston Corporation As Representatives of the Several...Neurocrine Biosciences Inc • December 3rd, 2001 • Biological products, (no disgnostic substances) • Maryland
AGREEMENTNeurocrine Biosciences Inc • November 12th, 1999 • Biological products, (no disgnostic substances) • Delaware
ARTICLE 1Employment Agreement • June 24th, 2005 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
PROMISSORY NOTENeurocrine Biosciences Inc • October 29th, 2004 • Biological products, (no disgnostic substances) • California
6,944,000 Shares NEUROCRINE BIOSCIENCES, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • February 19th, 2015 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
period beginning on the date of the issuance of the earnings release or the occurrence of the material news or material event, as applicable, unless J.P. Morgan and Deutsche Bank waive, in writing, such extension, except that such extension will not apply if (i) the Shares are “actively traded securities” (as defined in Regulation M of the Exchange Act), (ii) the Company meets the applicable requirements of paragraph (a)(1) of Rule 139 under the Securities Act of 1933, as amended, (the “Securities Act”) in the manner contemplated by NASD Conduct Rule 2711(f)(4), and (iii) the provisions of NASD Conduct Rule 2711(f)(4) are not applicable to any research reports relating to the Company published or distributed by any of the Underwriters during the 15 days before or after the last day of the Lock-up Period (before giving effect to such extension); provided, further, that the foregoing restrictions shall not apply to (1) transactions relating to Shares or other securities acquired in open
RECITALSEmployment Agreement • May 10th, 2004 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
NEUROCRINE BIOSCIENCES, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY RIGHTS AGENT AMENDED AND RESTATED PREFERRED SHARES RIGHTS AGREEMENT DATED AS OF JANUARY 11, 2002Rights Agreement • January 14th, 2002 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
Exhibit 1.1 Form of Underwriting AgreementUnderwriting Agreement • November 30th, 2000 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
ARTICLE ONE CONSULTING SERVICESConsulting Services Agreement • February 16th, 2005 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, dated as of October 17, 2001 (the "Effective Date") by and between NEUROCRINE BIOSCIENCES, INC., 10555 Science Center Drive, San Diego, California 92121 (hereinafter the "Company"), and Henry Pan, MD, PhD.,...Employment Agreement • November 13th, 2001 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
DATEDLicense Agreement • March 30th, 2001 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
ARTICLE IEmployment Agreement • April 10th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
by and between SCIENCE PARK CENTER LLC, a California limited liability company, as Borrower and STEWART TITLE GUARANTY COMPANY, as TrusteeNeurocrine Biosciences Inc • October 29th, 2004 • Biological products, (no disgnostic substances)
EXHIBIT 1.1Neurocrine Biosciences Inc • September 12th, 2003 • Biological products, (no disgnostic substances) • New York
NEUROCRINE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Common Stock Warrant Agreement • February 15th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
EXHIBIT 10.1 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into as of March 15, 2004 by and among Neurocrine Biosciences, Inc., a Delaware corporation (the "Company"), and Wyeth Holdings Corporation...Stock Purchase Agreement • March 17th, 2004 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
NEUROCRINE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Preferred Stock Warrant Agreement • February 15th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
ARTICLE 1 DEFINITIONSCollaboration Agreement • December 20th, 2002 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.2 PASTAN/FITZGERALD AND NEUROCRINE BIOSCIENCES, INC. PATENT LICENSE AGREEMENT PATENT LICENSE AGREEMENT dated as of April 28, 1998, between Ira Pastan and David J. FitzGerald (collectively, "Licensor") and Neurocrine Biosciences, Inc., a...Patent License Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • District of Columbia
INDEMNITY AGREEMENTIndemnity Agreement • November 1st, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , 2017 is made and entered into by and between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
ARTICLE 1 DEFINITIONSNeurocrine Biosciences Inc • November 12th, 1999 • Biological products, (no disgnostic substances)
1- 2 this Agreement or to renew it for a different term of not less than one (1) year.Security Agreement • August 14th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
1- 2 this Agreement or to renew it for a different term of not less than one (1) year.Employment Agreement • August 14th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
NEUROCRINE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • February 15th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN GLAXO GROUP LIMITEDCollaboration and License Agreement • August 14th, 2001 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
RECITALSConstruction Loan Agreement • November 14th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
ANDPreferred Shares Rights Agreement • June 16th, 1997 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
Exhibit 2.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made as of May 28, 1998, by and among Neurocrine Biosciences, Inc., a Delaware corporation (the "Parent") and the persons listed on the signature page...Registration Rights Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
